Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences Inks Deal to Provide Siena Biotech with Protein Biomarker Services


Proteome Sciences said this week it has signed an agreement with Siena Biotech making it the preferred supplier of protein and peptide biomarker services for Siena's drug development research.

The first project under the agreement calls for Proteome Sciences to provide a detailed analysis of post-translational modifications on a neurological disease-related protein. Such maps, the company noted in a statement, are "often used to confirm proof of disease mechanism and/or mode of action of new targeted therapeutics providing information to suppose go/no-go decisions in early drug development."

Siena's drug development efforts are focused in the neurodegenerative diseases and oncology spaces, both of which have been areas of concentration for Proteome Sciences. The company offers two SRM-MS assays for Alzheimer's research – its AD-TMT-SRM assay, which measures levels of nine Alzheimer's biomarkers in serum, and an assay for measuring levels of phosphorylated tau protein in brain tissue – and has recently begun moving into the clinical oncology market, signing agreements for cancer research with the Moffitt Cancer Center of Tampa, Fla., and the Buck Institute for Research on Aging in Novato, Calif. (PM 07/22/2011).

Proteome Sciences will be doing the Siena PTM work on a Thermo Scientific Orbitrap Velos, the company said.

Financial and other terms of the agreement were not disclosed.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.